Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment (Q47782948)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 December 2016

Language	Label	Description	Also known as
English	Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment	scientific article published on 18 December 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

author name string

Pavel Klein

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

Martin E Johnson

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

Jimmy Schiemann

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

John Whitesides

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

publication date

18 December 2016

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

58

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

e21-e25

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Lamotrigine extended-release as adjunctive therapy for partial seizures

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability

1 reference

https://api.crossref.org/works/10.1111%2FEPI.13631

21 January 2018

Identifiers

10.1111/EPI.13631

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/27988967

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47782948&oldid=2170685079"